iANTHUS CAPITAL HOLDINGS (ITHUF) Assets Average (2021 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Assets Average came in at $255.9 million in Q1 2026, down 5.84% year-on-year from $271.8 million in Q1 2025, and little changed quarter-over-quarter from $256.0 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Assets Average (2021 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Assets Average across 6 years of filings, most recently posting $255.9 million for Q1 2026.
- Assets Average for Q1 2026 came in at $255.9 million, down 5.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $255.9 million (down 5.84% YoY), and the FY2025 annual result was $263.5 million, down 3.91% from the prior year.
- Assets Average came in at $255.9 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, roughly flat from $256.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $362.0 million in Q2 2022 to a low of $255.9 million in Q1 2026.
- The 5-year median for Assets Average is $275.6 million (2024), against an average of $292.5 million.
- Across the five-year window, Assets Average decreased 0.61% in 2022 and slipped 18.64% in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Assets Average stood at $325.7 million in 2022, then declined by 13.5% to $281.8 million in 2023, then decreased by 3.78% to $271.1 million in 2024, then declined by 5.59% to $256.0 million in 2025, then decreased by 0.02% to $255.9 million in 2026.
- The last three Assets Average figures came in at $255.9 million (Q1 2026), $256.0 million (Q4 2025), and $262.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 40.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 15.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 7.30 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 552.96 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 4.77 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.29 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 3.37 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 2.21 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.29 Bn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn | 255.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 255.91 Mn |
| Dec 31, 2025 | 255.97 Mn |
| Sep 30, 2025 | 262.31 Mn |
| Jun 30, 2025 | 270.60 Mn |
| Mar 31, 2025 | 271.78 Mn |
| Dec 31, 2024 | 271.11 Mn |
| Sep 30, 2024 | 271.81 Mn |
| Jun 30, 2024 | 273.11 Mn |
| Mar 31, 2024 | 275.59 Mn |
| Dec 31, 2023 | 281.76 Mn |
| Sep 30, 2023 | 289.78 Mn |
| Jun 30, 2023 | 295.49 Mn |
| Mar 31, 2023 | 300.50 Mn |
| Dec 31, 2022 | 325.75 Mn |
| Sep 30, 2022 | 356.16 Mn |
| Jun 30, 2022 | 362.00 Mn |
| Mar 31, 2022 | 352.34 Mn |
| Dec 31, 2021 | 354.50 Mn |
| Sep 30, 2021 | 363.76 Mn |
| Jun 30, 2021 | 364.20 Mn |